Intersect ENT In-Date
Intersect ENT, now part of Medtronic, specializes in drug-delivery sinus implants designed to treat chronic rhinosinusitis and improve postoperative outcomes following sinus surgery. Its core products—PROPEL, PROPEL Mini, and PROPEL Contour—are bioresorbable steroid-eluting implants that deliver anti-inflammatory medication directly to the sinus tissue while propping open the sinus cavities during healing. Intersect ENT also developed the SINUVA implant, an in-office option for recurrent nasal polyps. By combining localized drug delivery with mechanical support, Intersect ENT offers ENT specialists innovative, minimally invasive solutions to reduce inflammation, minimize the need for oral steroids, and improve long-term sinus health.